UP-818-CC

N/A

Report date: 2024/04/17 14:09:09
NME

Base Information

Drug NameUP-818-CC
Drug Alias NameUP-818-CCTISA-818
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjuryStomatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai STA Pharmaceutical Product Co LtdJiangyin Usun Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAitiya (Shanghai) Pharmaceutical Co LtdShanghai STA Pharmaceutical Product Co LtdJiangyin Usun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjuryStomatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A